Nishan de Silva
Director/Board Member at Alita Pharmaceuticals, Inc.
Net worth: 4 870 $ as of 2024-04-29
Network origin in Nishan de Silva first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
15
| Extinct | Pharmaceuticals: Major | 15 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
| Public Company | Biotechnology | 8 | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Alita Pharmaceuticals, Inc.
 Alita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alita Pharmaceuticals, Inc. develops, manufactures and distributes urologic and female healthcare products. It offers product testing, research and development services. The company was founded by Carole S. Ben-Maimon and Warburg Pincus in September 2006 and is headquartered in Radnor, PA.
3
| Private Company | Pharmaceuticals: Major | 3 |
Transposagen Biopharmaceuticals, Inc.
 Transposagen Biopharmaceuticals, Inc. BiotechnologyHealth Technology Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY.
2
| Holding Company | Biotechnology | 2 |
| Public Company | Pharmaceuticals: Major | 2 | |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nishan de Silva via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer Founder Chief Executive Officer Chief Operating Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Doctorate Degree Undergraduate Degree Doctorate Degree | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Investment Committee Member Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Analyst | |
| University of Wisconsin | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Warburg Pincus & Company US LLC
 Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal Consultant / Advisor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| San Diego State University | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| Drexel University | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| INTERMUNE INC | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree Chief Executive Officer | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal Masters Business Admin | |
| University of California, Irvine | College/University | Masters Business Admin Undergraduate Degree | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Topokine Therapeutics, Inc.
 Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Founder Founder | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Brown University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| MELINTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Western Ontario | College/University | Doctorate Degree Doctorate Degree | |
ReSearch Pharmaceutical Services LLC
 ReSearch Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services ReSearch Pharmaceutical Services LLC provides clinical research services to the bio-pharmaceutical industry. Its services include analytical and product development, clinical operations, data services, medical and regulatory affairs, quality and training services. The company was founded by Daniel M. Perlman in 1998 and is headquartered in Fort Washington, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
BC Advantage Funds Ltd.
 BC Advantage Funds Ltd. Investment ManagersFinance Founded 2003, BC Advantage Funds (VCC) Ltd is a venture capital firm, headquartered in Canada. | Investment Managers | Director/Board Member Private Equity Investor | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| GERON CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| ARQULE, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ALLON THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
HUYA Bioscience International LLC
 HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| University of Maryland | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Weill Cornell Medical College | College/University | Doctorate Degree Corporate Officer/Principal | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | General Counsel Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 45 |
| Canada | 6 |
| Ireland | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 15 |
| Finance | 6 |
| Commercial Services | 5 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 305 |
| Corporate Officer/Principal | 144 |
| Independent Dir/Board Member | 87 |
| Chairman | 72 |
| Chief Executive Officer | 56 |
Most connected contacts
| Insiders | |
|---|---|
| Jonathan Leff | 45 |
| Robert Spiegel | 30 |
| Frank Holler | 29 |
| Michael Weiser | 26 |
| Avtar Dhillon | 25 |
| Patrick Zenner | 24 |
| Carrie Cox | 22 |
| Sean Murphy | 22 |
| Lars Ekman | 21 |
| Paul Grayson | 21 |
| Timothy Barabe | 21 |
| Cecilia Gonzalo | 20 |
| Jim J. Miller | 19 |
| Alexander R. Giaquinto | 19 |
| Scott Myers | 18 |
- Stock Market
- Insiders
- Nishan de Silva
- Company connections
